Combination therapy of antibiotics can be used against multi drug resistant bacteria.
INTRODUCTION
Pseudomonas aeruginosa is the most common pathogen that causes nosocomial infections in patients with compromised host defense mechanisms (1), which are infections that patients acquire during the course of receiving treatment for other conditions, causes the most severe and life threatening infections with a mortality rate of 50% particularly in hospitalized patients with serious underlying diseases, in intensive care patients, severe burns patients, cancer and transplant patients who are immunosuppressed (2). The high mortality associated with these infections is due to a combination of weakened host defenses, bacterial resistance to antibiotics, and the production of extracellular bacterial enzymes and toxins (3), adding to its pathogenicity, P. aeruginosa has minimal nutritional requirements and can tolerate a wide variety of physical conditions, it has the ability to adapt in many ecological niches, from water and soil to plant and animal tissues (4). The bacterium capable of utilizing a wide range of organic compounds as food sources, thus giving it an exceptional ability to colonize ecological niches where nutrients are limited (1).
P. aeruginosa is notorious for its resistance to antibiotics, it is naturally resistant to many antibiotics due to the low permeability barrier afforded by its Gram-negative outer membrane, the action of multidrug efflux pumps, and its tendency to colonize surfaces in a biofilm form make the cells impervious to therapeutic concentrations antibiotics (4). Since its natural habitat is the soil, living in association with the Bacilli, Actinomycetes and Molds, it has developed resistance to a variety of their naturally-occurring antibiotics, also it maintains antibiotic resistance plasmids, both R-factors and RTFs, and it is able to transfer these genes by horizontal gene transfer, mainly transduction and conjugation (5).
Only a few antibiotics are effective against P. aeruginosa, including fluoroquinolones, gentamicin and imipenem, and even these antibiotics are not effective against all strains (3). Monotherapy is recommended for uncomplicated urinary tract infections, while combination therapy is recommended for severe infections, such as bacteraemia and pneumonia, at least in some cases, the advantage of combination therapy remains a matter of debate (6), but, on the other side, combination therapy was considered one way to overcome this problem, both in animal models and in clinical therapy (7), it is generally used to increase bactericidal activity and/or the rate of killing in vivo, and to prevent the emergence of drug resistance, it is also used to broaden the antimicrobial spectrum in ill patients while awaiting a bacteriologic diagnosis or because patients have suspected or proven polymicrobial infections (8). The increased clinical response to combination therapy is explained to be due to synergism between the antibiotics used. Synergism of a combination of antibiotics can be expressed as fractional inhibitory concentration indices (FICi) derived from a checker board titration (9). Another way to detect synergism is by performing time kill curve studies (10).
MATERIALS AND METHODS

Samples collection
Two clinical isolates of multi drug resistant P. aeruginosa were collected from patients with chronic otitis media, identified by conventional methodology (11) .
Antibiotics Susceptibility
The susceptibility of isolates were re-examined against 10 types of standard antibiotics that differ in their spectrum and mechanisms of action, by using the Kirby-Bauer method, according to (12). That is Amoxcillin, Cephalixin, Erythromycin, Tetracyclin, Tobramycin, Gentamicin, Streptomycin, Rifampicin, Ciprofloxacin, and Tri-methoprim.
Minimal Inhibitory Concentrations (MICs)
MIC was determined for each antibiotic separately by broth micro dilution assay according to (13), sterile stock solutions of antibiotics were prepared by dissolving 1mg of 
Activity of antibiotics combinations on bacterial growth
The activity of two combinations regimen of the antibiotics was tested on P.
aeruginosa according to ( Each combination were mixed with 25ml nutrient agar (with consideration that each ml of nutrient agar medium will have the same concentration of MIC of two combined antibiotics), after the medium was cooled to 45C
• , poured in plates, then inoculated with 10 6 CFU/ml of P.
aeruginosa and incubated at 37C
• for 24hr. Antibiotics combination-untreated plates were made as a control plate, Growth results were then recorded (16).
RESULTS AND DISCUSSION
The results of P. aeruginosa identification were appeared after 24hr. incubation at 37C
• as a growth with blue-green pigmentation due to pyocyanin production on nutrient agar, while it appeared as a pale green colonies due to inability to ferment lactose on MacConkey agar medium, in addition to the fruity odor of aminoacetaphenone and positive reaction to oxidase. Under microscope, the microorganisms appeared Gram negative rods with no particular arrangement.
Isolates of P. aeruginosa are identified from clinical specimen by their production of pyocyanin, a blue, water-soluble, non fluorescent, phenazine pigment, in addition to their colonial morphology (11) . P. aeruginosa is the only species of Pseudomonas or Gramnegative rods known to excrete pyocyanin (17) .
In comparison with standard tables of evolution inhibition zones in the WHO report (18), P. aeruginosa was showed a differences in their susceptibility to antibiotics under investigation, the results of antibiotics susceptibility and MIC were displayed in Table(1) and The susceptibility patterns of P. aeruginosa vary geographically, and susceptibility tests should be done as an adjunct to selection of antimicrobial therapy (19).
Antibiotics combination activity
After turbidimetric measurements at 540 nm, the absorbance values of antibiotics combinations Table ( 
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